
James French Hill Periodic Transaction Report
Filed Jan 23, 2026 · House Clerk · 4 transactions
U.S. Representative · R · AR-02 · All trades by James French Hill
On January 23, 2026, Rep. James French Hill (R-AR-02) filed a periodic transaction report with the House Clerk disclosing 4 transactions (4 sales) dated Dec 31, 2025.
The filing covers 4 tickers, including $KD, $PFE, $SFL, $SOLV.
Reported amount ranges sum to $131K–$365K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 23 days.
Source document: House Clerk filing 20033661
Sample · the intelligence layer
James French Hill · Sold $PFE · Dec 31 · $100K–$250K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow James French Hill
Get an email the moment James French Hill files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | KDKDKyndryl Holdings, Inc. Common Stock | Kyndryl Holdings, Inc. Common Stock (KD) | sell | — | $1K–$15K | 23d |
| Dec 31, 2025 | PFEPFEPfizer, Inc. Common Stock | Pfizer, Inc. Common Stock (PFE) | sell | — | $100K–$250K | 23d |
| Dec 31, 2025 | SFLSFLSFL Corporation Ltd | SFL Corporation Ltd (SFL) | sell | — | $15K–$50K | 23d |
| Dec 31, 2025 | SOLVSOLVSolventum Corporation Common Stock | Solventum Corporation Common Stock (SOLV) | sell | — | $15K–$50K | 23d |
Other recent filings by James French Hill
- PTR filed Jul 24, 202514 trades · MKL, BX, FTRE, INTC
- PTR filed Feb 4, 20251 trade · CVS
- PTR filed Jan 10, 20242 trades · PYPL, SCHW
- PTR filed Dec 13, 202311 trades · PCH, FIS, INTC, MKL
- PTR filed Mar 23, 20231 trade
- PTR filed Mar 16, 20231 trade
← All congressional filings, newest first
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →